NCT01389752View on ClinicalTrials.gov

A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Depressive Disorder, Major

Interventions

DRUG

LY2216684

Administered orally

DRUG

Activated Charcoal

Administered orally

Trial Locations (1)

75247

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT01389752 - A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects | Biotech Hunter | Biotech Hunter